Early research (Phase 1)Study completedNCT00574600
What this trial is testing
Safety of and Immune Response to Two HIV Vaccines: SAAVI DNA-C2 Boosted With SAAVIMVA-C, in HIV-Negative Adults
Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 48